|1.||Zorzi, Giovanna: 1 article (01/2013)|
|2.||Nardocci, Nardo: 1 article (01/2013)|
|3.||Falcioni, Tania: 1 article (03/2008)|
|4.||Papa, Stefano: 1 article (03/2008)|
|5.||Gasol, Josep M: 1 article (03/2008)|
|6.||Sermer, David: 1 article (12/2007)|
|7.||Quercia, Nada: 1 article (12/2007)|
|8.||Chong, Karen: 1 article (12/2007)|
|9.||Chitayat, David: 1 article (12/2007)|
|10.||Tolwani, R J: 1 article (02/2006)|
|1.||Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile)
01/01/2013 - "The Neuroaxonal Dystrophies (NADs) are a group of clinically and genetically heterogeneous neurodegenerative conditions. "
01/01/2013 - "NADs comprise two main diseases: pantothenate-kinase associated neurodegeneration (PKAN) and infantile neuroaxonal dystrophy (INAD). "
02/01/2006 - "The neuroaxonal dystrophies (NADs) in human beings are fatal, inherited, neurodegenerative diseases with distinctive pathological features. "
|2.||Neurodegenerative Diseases (Neurodegenerative Disease)
|4.||Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)
12/15/2007 - "The severity of the upper limb defects, the involvement of lower limbs, and the absence of eyelid coloboma and polythelia excluded the possibility of other conditions associated with acrofacial dysostosis (AFD) including Nager acrofacial dysostosis syndrome (NADS) and postaxial acrofacial dysostosis syndrome (POADS). "
|1.||Surface-Active Agents (Surfactants)